For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Administer with care – chelation therapy and IV vitamin C
Wednesday 4 July 2018, 05:30 AM
Tane Taylor encourages GPs to do the reading and reach their own conclusions about chelation therapy
CORRECTION:
This story has been amended to give the correct number of TACT study participants of 1708, not 17000.
Chelation therapy – does it work?
“In my 20 years of observation, yes,” Auckland GP and RNZCGP assessor Tane Taylor told about 20 attendees of his
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.